Your browser doesn't support javascript.
Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals.
Mahoney, Monica V; Bhagat, Hita; Christian, Robbie; Del Rio, Carlos; Hohmeier, Kenneth C; Klepser, Michael E; Pogue, Jason M.
  • Mahoney MV; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Bhagat H; Department of Pharmacy, Community Health Network, Indianapolis, Indiana.
  • Christian R; Baton Rouge General, Baton Rouge, Louisiana.
  • Del Rio C; Division of Infectious Diseases, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Hohmeier KC; Department of Clinical Pharmacy & Translational Science, University of Tennessee Health Science Center, Nashville, Tennessee.
  • Klepser ME; Ferris State University College of Pharmacy, Big Rapids, Michigan.
  • Pogue JM; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Antimicrob Steward Healthc Epidemiol ; 2(1): e112, 2022.
Article in English | MEDLINE | ID: covidwho-1972412
ABSTRACT
Although pharmacists are key members of the healthcare team, they are currently ineligible to independently prescribe the oral coronavirus disease 2019 (COVID-19) antivirals. We report the roles pharmacists have undertaken during the COVID-19 pandemic and provide evidence for the support of independent oral COVID-19 antiviral prescribing.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article